(53) found APOBEC3B to be consistently enriched in patients with gastric-type cervical adenocarcinoma having a favorable prognosis; this suggests that recurrent APOBEC3B alterations have potential prognostic value in the immunotherapy of gynecological cancers. Here, APOBEC3B is linked to cervical adenocarcinoma.